BioNexus Gene Lab Corp Common stock
Symbol: BGLC (NASDAQ)
Company Description:
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
- Today's Open: $5.33
- Today's High: $5.455
- Today's Low: $5.15
- Today's Volume: 61.03K
- Yesterday Close: $5.36
- Yesterday High: $5.5
- Yesterday Low: $5.26
- Yesterday Volume: 33.64K
- Last Min Volume: 1
- Last Min High: $5.31
- Last Min Low: $5.31
- Last Min VWAP: $5.31
- Name: BioNexus Gene Lab Corp Common stock
- Website: https://www.bionexusgenelab.com
- Listed Date: 2020-03-11
- Location: KUALA LUMPUR, N8
- Market Status: Active
- CIK Number: 0001737523
- SIC Code: 8071
- SIC description: SERVICES-MEDICAL LABORATORIES
- Market Cap: $9.59M
- Round Lot: 100
- Outstanding Shares: 1.80M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-08-14 | NT 10-Q | View |
2025-07-30 | 8-K | View |
2025-06-23 | 8-K | View |
2025-05-15 | 10-Q | View |
2025-04-30 | 8-K | View |
2025-04-29 | 10-K/A | View |
2025-04-15 | 10-K | View |
2025-04-10 | 8-K | View |
2025-04-03 | 8-K | View |
2025-03-31 | NT 10-K | View |
2025-03-25 | 8-K | View |
2025-03-07 | 8-K | View |
2025-03-05 | 8-K | View |
2025-02-28 | DEFR14A | View |
2025-02-27 | DEF 14A | View |
2025-02-14 | 8-K | View |
2025-02-10 | PRE 14A | View |
2025-01-02 | 8-K | View |
2024-11-15 | 10-Q | View |
2024-11-14 | NT 10-Q | View |